VIRGINIA DEPARTMENT OF HEALTH EMERGENCY OPERATIONS PLAN

1
VIRGINIA DEPARTMENT OF HEALTHEMERGENCY
OPERATIONS PLAN

• PANDEMIC INFLUENZA PLAN
• ANTIVIRAL DRUG DISTRIBUTION

2
PLAN COMPONENTS

• ACQUISITION
• VIRGINIAS ALLOCATION UNDER THE HHS
  PANDEMIC INFLUENZA PLAN IS 773,304 COURSES
• COMMONWEALTH OF VIRGINIA HAS PURCHASED
  785,000 COURSES FOR USE IN A INFLUENZA PANDEMIC
  
• STORAGE
• A NATIONAL DRUG DISTRIBUTION COMPANY WAS
  SELECTED TO STORE AND DISTRIBUTE PANDEMIC
  ANTIVIRALS

3
PLAN COMPONENTS

• DISTRIBUTION
• CONTRACT PROVIDES FOR DISTRIBUTION FROM
  STORAGE SITE TO THE DISPENSING LOCATION
• REQUIRES NEXT DAY DELIVERY
• ADDITIONAL REDUNDACY AVAILABLE VIA EP R
  CONTRACT WITH A NATIONAL PACKAGE DELIVERY COMPANY
• DISPENSING
• PROVIDES FOR THE DISPENSING OF ANTIVIRAL
  MEDICATIONS TO THE
• END USER
• PATIENT WILL NEED TO HAVE A PRESCRIPTION TO
  RECEIVE ANTIVIRALS FROM THE COMMONWEALTHS SUPPLY

4
PLAN COMPONENTS

• DISPENSING (CONTINUED)
• INTENDED FOR TREATMENT AND NOT FOR
  PROPHYLAXSIS
• DISPENSED AT NO CHARGE TO THE PATIENT

5
ANTIVIRAL DISPENSING NETWORK

• ISSUES
• APPROPRIATE NUMBER OF DISPENSING SITES
• ESTIMATED THAT IT WOULD REQUIRE BETWEEN
  450 TO 550 COMMUNITY BASED SITES TO ADEQUATELY
  MANAGE THE PROJECTED DISPENSING NEEDS (ACTUAL
  NUMBER AS OF 11-30-2007 IS 685)
• APPROPRIATE GEOGRAPHIC AND DEMOGRAPHIC
  DISTRIBUTION OF SITES
• OBJECTIVES WERE ESTABLISHED SO THAT
  EVERYONE SHOULD BE WITHIN 12 MILES OF A
  DISEPENSING SITE AND THAT EACH SITE SHOULD
  SERVICE NO MORE THAN 17,000 PEOPLE

6
ANTIVIRAL DISPENSING NETWORK

• EQUITABLE DISTRIBUTION OF SITES AMONG PHARMACY
  INDUSTRY SEGMENTS
• APPROXIMATELY 1100 CHAIN PHARMACIES AND
  500 INDEPENDENTLY OWNED PHARMACIES IN VIRGINIA
• 462 CHAIN PHARMACIES AND 223 INDEPENDENT
  PHARMACIES HAVE INDICATED THEY ARE INTERESTED IN
  PARTICIPATING IN THE DISPENSING NETWORK
• OBJECTIVE OF MAINTAINING SAME RATIO OF
  SEGMENTS WITHIN THE NETWORK AS EXIST AMONG ALL
  LICENSED PHARMACIES

7
ANTIVIRAL DISPENSING NETWORK

• IDENTIFYING SPECIAL NEEDS POPULATIONS
• SPECIFIC EMPHASIS ON SEGMENTS OF THE
  POPULATION THAT WOULD NOT BE CAPABLE OF RECEIVING
  SERVICE VIA NORMAL DISTRIBUTION (EXAMPLES
  INCARCERATED OR INSTITUTIONAL POPULATIONS)
• IDENTIFYING ATYPICAL DISPENSING SITES TO MEET
  SPECIFIC NEEDS

8
ANTIVIRAL DISPENSING NETWORK

• ESTABLISH A SOFTWARE PROGRAM THAT LINKS ALL
  PARTICPATING SITES AND PROVIDES DISTRIBUTION AND
  UTILIZATION DATA AND CONTROL TO DESIGNATED
  PARTIES
• DISTRIBUTION DATA WILL BE PROVIDED BY THE
• STORAGE VENDOR
• UTILIZATION DATA WILL BE PROVIDED BY DISPENSING
  SITES

9
FUTURE ACTIVITIES/CHALLENGES

• INCLUSION OF VIRGINIAS ANTIVIRAL CACHE IN A SLEP
  (SHELF LIFE EXTENSION PROGRAM)
• ACQUISITION OF THE PEDIATRIC DOSAGE FORM OF
  TAMIFLU
• COMPLETION OF A MOU (MEMORANDUM OF UNDERSTANDING)
  WITH PARTICIPATING ENTITIES IN THE ANTIVIRAL
  DISPENSING NETWORK
• REFINE EXISTING SITES TO MEET NETWORK OBJECTIVES
• IDENTIFY AND REACH OUT TO INDEPENDENT PHARMACIES
  LOCATED IN UNDERSERVED AREAS (PIEDMONT, SOUTH
  CENTRAL VA, WESTERN TIDEWATER, MIDDLE AND
  NORTHERN NECK, EASTERN SHORE)

10
FUTURE ACTIVITIES/CHALLENGES, Continued

• REFINE RESPONSIBILITIES WITH DEPARTMENT OF
  DEFENSE
• CONTINUE TO IDENTIFY SPECIAL NEEDS POPULATIONS
• IDENTIFY AND REACH OUT TO ATYPICAL DISPENSING
  SITES
• CONTINUE DEVELOPMENT OF PROTOTYPE SOFTWARE FOR
  ANTIVIRAL DISTRIBUTION (EX. EDIT LEVELS TO
  PREVENT DUPLICATE FILLS, UNIQUE IDENTIFIERS,
  SUPPORT, PRICING)